These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Delaware
|
|
94-3112828
|
|
(State or other jurisdiction of
|
|
(I.R.S. Employer
|
|
incorporation or organization)
|
|
Identification No.)
|
|
Large accelerated filer
x
|
|
Accelerated filer
o
|
|
|
|
|
|
Non-accelerated filer
o
|
|
Smaller reporting company
o
|
|
(Do not check if a smaller reporting company)
|
|
|
|
|
PAGE
|
|
PART I. FINANCIAL INFORMATION
|
|
|
Item 1. Financial Statements:
|
|
|
•
|
Success in the markets of our or our licensees’ products;
|
|
•
|
Sources of competition;
|
|
•
|
Research and development costs and improvements in technology;
|
|
•
|
Sources, amounts and concentration of revenue, including royalties;
|
|
•
|
Success in renewing license agreements;
|
|
•
|
Technology product development;
|
|
•
|
Outcome and effect of current and potential future intellectual property litigation and other significant litigation;
|
|
•
|
Dispositions, acquisitions, mergers or strategic transactions and our related integration efforts;
|
|
•
|
Write-down of assets;
|
|
•
|
Pricing policies of our licensees;
|
|
•
|
Changes in our strategy and business model;
|
|
•
|
Deterioration of financial health of commercial counterparties and their ability to meet their obligations to us;
|
|
•
|
Engineering, marketing and general and administration expenses;
|
|
•
|
Contract revenue;
|
|
•
|
Operating results;
|
|
•
|
International licenses and operations;
|
|
•
|
Effects of changes in the economy and credit market on our industry and business;
|
|
•
|
Ability to identify, attract, motivate and retain qualified personnel;
|
|
•
|
Growth in our business;
|
|
•
|
Methods, estimates and judgments in accounting policies;
|
|
•
|
Adoption of new accounting pronouncements;
|
|
•
|
Effective tax rates;
|
|
•
|
Realization of deferred tax assets/release of deferred tax valuation allowance;
|
|
•
|
Trading price of our Common Stock;
|
|
•
|
Internal control environment;
|
|
•
|
Corporate governance;
|
|
•
|
The level and terms of our outstanding debt;
|
|
•
|
Resolution of the governmental agency matters involving us;
|
|
•
|
Litigation expenses;
|
|
•
|
Protection of intellectual property;
|
|
•
|
Terms of our licenses and amounts owed under license agreements;
|
|
•
|
Indemnification and technical support obligations;
|
|
•
|
Issuances of our securities, which could involve restrictive covenants or be dilutive to our existing stockholders; and
|
|
•
|
Likelihood of paying dividends or repurchasing securities.
|
|
|
September 30,
2012 |
|
December 31,
2011 |
||||
|
|
(In thousands, except shares
and par value)
|
||||||
|
ASSETS
|
|
|
|
|
|
||
|
Current assets:
|
|
|
|
|
|
||
|
Cash and cash equivalents
|
$
|
152,206
|
|
|
$
|
162,244
|
|
|
Marketable securities
|
54,880
|
|
|
127,212
|
|
||
|
Accounts receivable
|
452
|
|
|
1,026
|
|
||
|
Prepaids and other current assets
|
9,759
|
|
|
8,096
|
|
||
|
Deferred taxes
|
1,807
|
|
|
2,798
|
|
||
|
Total current assets
|
219,104
|
|
|
301,376
|
|
||
|
Intangible assets, net
|
160,408
|
|
|
181,955
|
|
||
|
Goodwill
|
124,969
|
|
|
115,148
|
|
||
|
Property, plant and equipment, net
|
84,255
|
|
|
81,105
|
|
||
|
Deferred taxes, long-term
|
7,575
|
|
|
7,531
|
|
||
|
Other assets
|
5,514
|
|
|
6,539
|
|
||
|
Total assets
|
$
|
601,825
|
|
|
$
|
693,654
|
|
|
LIABILITIES &
STOCKHOLDERS’ EQUITY
|
|
|
|
|
|
||
|
Current liabilities:
|
|
|
|
|
|
||
|
Accounts payable
|
$
|
7,841
|
|
|
$
|
16,567
|
|
|
Accrued salaries and benefits
|
29,785
|
|
|
31,763
|
|
||
|
Accrued litigation expenses
|
10,035
|
|
|
10,502
|
|
||
|
Other accrued liabilities
|
13,448
|
|
|
6,479
|
|
||
|
Total current liabilities
|
61,109
|
|
|
65,311
|
|
||
|
Convertible notes, long-term
|
143,875
|
|
|
133,493
|
|
||
|
Long-term imputed financing obligation
|
45,878
|
|
|
43,793
|
|
||
|
Long-term income taxes payable
|
9,383
|
|
|
9,946
|
|
||
|
Other long-term liabilities
|
10,754
|
|
|
11,317
|
|
||
|
Total liabilities
|
270,999
|
|
|
263,860
|
|
||
|
Commitments and contingencies (Notes 7 and 13)
|
|
|
|
|
|
||
|
Stockholders’ equity:
|
|
|
|
|
|
||
|
Convertible preferred stock, $.001 par value:
|
|
|
|
|
|
||
|
Authorized: 5,000,000 shares
|
|
|
|
|
|
||
|
Issued and outstanding: no shares at September 30, 2012 and December 31, 2011
|
—
|
|
|
—
|
|
||
|
Common stock, $.001 par value:
|
|
|
|
|
|
||
|
Authorized: 500,000,000 shares
|
|
|
|
|
|
||
|
Issued and outstanding: 110,879,633 shares at September 30, 2012 and 110,267,145 shares at December 31, 2011
|
111
|
|
|
110
|
|
||
|
Additional paid-in capital
|
1,068,871
|
|
|
1,049,716
|
|
||
|
Accumulated deficit
|
(737,847
|
)
|
|
(619,643
|
)
|
||
|
Accumulated other comprehensive loss
|
(309
|
)
|
|
(389
|
)
|
||
|
Total stockholders’ equity
|
330,826
|
|
|
429,794
|
|
||
|
Total liabilities and stockholders’ equity
|
$
|
601,825
|
|
|
$
|
693,654
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
September 30,
|
|
September 30,
|
||||||||||||
|
|
2012
|
|
2011
|
|
2012
|
|
2011
|
||||||||
|
|
(In thousands, except per share amounts)
|
||||||||||||||
|
Revenue:
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Royalties
|
$
|
57,361
|
|
|
$
|
96,216
|
|
|
$
|
175,127
|
|
|
$
|
216,421
|
|
|
Contract revenue
|
169
|
|
|
4,047
|
|
|
1,481
|
|
|
12,583
|
|
||||
|
Total revenue
|
57,530
|
|
|
100,263
|
|
|
176,608
|
|
|
229,004
|
|
||||
|
Operating costs and expenses:
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Cost of revenue*
|
7,529
|
|
|
7,425
|
|
|
22,032
|
|
|
16,632
|
|
||||
|
Research and development*
|
30,674
|
|
|
32,318
|
|
|
107,415
|
|
|
79,855
|
|
||||
|
Marketing, general and administrative*
|
24,255
|
|
|
48,952
|
|
|
91,283
|
|
|
119,416
|
|
||||
|
Restructuring charges
|
6,622
|
|
|
—
|
|
|
6,622
|
|
|
—
|
|
||||
|
Impairment of goodwill and long-lived assets
|
35,471
|
|
|
—
|
|
|
35,471
|
|
|
—
|
|
||||
|
Costs of restatement and related legal activities
|
79
|
|
|
832
|
|
|
192
|
|
|
2,703
|
|
||||
|
Gain from settlement
|
—
|
|
|
—
|
|
|
—
|
|
|
(6,200
|
)
|
||||
|
Total operating costs and expenses
|
104,630
|
|
|
89,527
|
|
|
263,015
|
|
|
212,406
|
|
||||
|
Operating income (loss)
|
(47,100
|
)
|
|
10,736
|
|
|
(86,407
|
)
|
|
16,598
|
|
||||
|
Interest income and other income (expense), net
|
(12
|
)
|
|
172
|
|
|
175
|
|
|
471
|
|
||||
|
Interest expense
|
(7,121
|
)
|
|
(6,350
|
)
|
|
(20,420
|
)
|
|
(18,462
|
)
|
||||
|
Interest and other income (expense), net
|
(7,133
|
)
|
|
(6,178
|
)
|
|
(20,245
|
)
|
|
(17,991
|
)
|
||||
|
Income (loss) before income taxes
|
(54,233
|
)
|
|
4,558
|
|
|
(106,652
|
)
|
|
(1,393
|
)
|
||||
|
Provision for income taxes
|
3,865
|
|
|
4,080
|
|
|
11,552
|
|
|
12,944
|
|
||||
|
Net income (loss)
|
$
|
(58,098
|
)
|
|
$
|
478
|
|
|
$
|
(118,204
|
)
|
|
$
|
(14,337
|
)
|
|
Net income (loss) per share:
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Basic
|
$
|
(0.52
|
)
|
|
$
|
0.00
|
|
|
$
|
(1.07
|
)
|
|
$
|
(0.13
|
)
|
|
Diluted
|
$
|
(0.52
|
)
|
|
$
|
0.00
|
|
|
$
|
(1.07
|
)
|
|
$
|
(0.13
|
)
|
|
Weighted average shares used in per share calculation:
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Basic
|
110,826
|
|
|
112,334
|
|
|
110,580
|
|
|
109,997
|
|
||||
|
Diluted
|
110,826
|
|
|
115,552
|
|
|
110,580
|
|
|
109,997
|
|
||||
|
Cost of revenue
|
$
|
5
|
|
|
$
|
90
|
|
|
$
|
20
|
|
|
$
|
499
|
|
|
Research and development
|
$
|
2,221
|
|
|
$
|
2,775
|
|
|
$
|
7,572
|
|
|
$
|
7,777
|
|
|
Marketing, general and administrative
|
$
|
2,863
|
|
|
$
|
4,354
|
|
|
$
|
10,438
|
|
|
$
|
13,262
|
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
|
September 30,
|
|
September 30,
|
||||||||||||
|
(In thousands)
|
|
2012
|
|
2011
|
|
2012
|
|
2011
|
||||||||
|
Net income (loss)
|
|
$
|
(58,098
|
)
|
|
$
|
478
|
|
|
$
|
(118,204
|
)
|
|
$
|
(14,337
|
)
|
|
Other comprehensive income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Unrealized gain (loss) on marketable securities, net of tax
|
|
8
|
|
|
(79
|
)
|
|
80
|
|
|
(46
|
)
|
||||
|
Total comprehensive income (loss)
|
|
$
|
(58,090
|
)
|
|
$
|
399
|
|
|
$
|
(118,124
|
)
|
|
$
|
(14,383
|
)
|
|
|
Nine Months Ended
|
||||||
|
|
September 30,
|
||||||
|
|
2012
|
|
2011
|
||||
|
|
(In thousands)
|
||||||
|
Cash flows from operating activities:
|
|
|
|
|
|
||
|
Net loss
|
$
|
(118,204
|
)
|
|
$
|
(14,337
|
)
|
|
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
|
|
|
|
|
|
||
|
Impairment of goodwill and long-lived assets
|
35,471
|
|
|
—
|
|
||
|
Stock-based compensation
|
18,030
|
|
|
21,538
|
|
||
|
Depreciation
|
9,583
|
|
|
8,588
|
|
||
|
Amortization of intangible assets
|
23,535
|
|
|
12,908
|
|
||
|
Non-cash interest expense and amortization of convertible debt issuance costs
|
10,856
|
|
|
9,326
|
|
||
|
Deferred tax benefit
|
(39
|
)
|
|
(3,413
|
)
|
||
|
Non-cash acquisition of patents
|
—
|
|
|
(3,000
|
)
|
||
|
Change in operating assets and liabilities, net of effects of acquisitions:
|
|
|
|
|
|
||
|
Accounts receivable
|
574
|
|
|
2,823
|
|
||
|
Prepaid expenses and other assets
|
6,744
|
|
|
5,550
|
|
||
|
Accounts payable
|
(9,171
|
)
|
|
12,559
|
|
||
|
Accrued salaries and benefits and other accrued liabilities
|
4,009
|
|
|
(9,475
|
)
|
||
|
Accrued litigation expenses
|
(467
|
)
|
|
5,770
|
|
||
|
Income taxes payable
|
(665
|
)
|
|
2,174
|
|
||
|
Net cash provided by (used in) operating activities
|
(19,744
|
)
|
|
51,011
|
|
||
|
Cash flows from investing activities:
|
|
|
|
|
|
||
|
Acquisition of business, net of cash acquired
|
(46,278
|
)
|
|
(167,381
|
)
|
||
|
Purchases of marketable securities
|
(77,562
|
)
|
|
(94,189
|
)
|
||
|
Maturities of marketable securities
|
149,486
|
|
|
254,322
|
|
||
|
Purchases of property, plant and equipment
|
(15,802
|
)
|
|
(14,950
|
)
|
||
|
Acquisition of intangible assets
|
(1,700
|
)
|
|
(210
|
)
|
||
|
Proceeds from sale of marketable security
|
—
|
|
|
11
|
|
||
|
Net cash provided by (used in) investing activities
|
8,144
|
|
|
(22,397
|
)
|
||
|
Cash flows from financing activities:
|
|
|
|
|
|
||
|
Proceeds received from issuance of common stock under employee stock plans
|
1,728
|
|
|
9,482
|
|
||
|
Payments under installment payment arrangement
|
(149
|
)
|
|
(861
|
)
|
||
|
Principal payments against lease financing obligation
|
(17
|
)
|
|
(453
|
)
|
||
|
Proceeds from landlord for tenant improvements
|
—
|
|
|
8,800
|
|
||
|
Payment to redeem contingently redeemable common stock pursuant to the settlement agreement with Samsung
|
—
|
|
|
(100,000
|
)
|
||
|
Net cash provided by financing activities
|
1,562
|
|
|
(83,032
|
)
|
||
|
Net decrease in cash and cash equivalents
|
(10,038
|
)
|
|
(54,418
|
)
|
||
|
Cash and cash equivalents at beginning of period
|
162,244
|
|
|
215,262
|
|
||
|
Cash and cash equivalents at end of period
|
$
|
152,206
|
|
|
$
|
160,844
|
|
|
|
|
|
|
||||
|
Non-cash investing and financing activities during the period:
|
|
|
|
|
|
||
|
Property, plant and equipment received and accrued in accounts payable and other accrued liabilities
|
$
|
2,686
|
|
|
$
|
1,194
|
|
|
Non-cash obligation for property, plant and equipment
|
$
|
2,008
|
|
|
$
|
—
|
|
|
Common stock issued pursuant to acquisition
|
$
|
—
|
|
|
$
|
88,438
|
|
|
|
Total
|
||
|
|
(in thousands)
|
||
|
Cash
|
$
|
182
|
|
|
Property and equipment
|
51
|
|
|
|
Other tangible assets
|
36
|
|
|
|
Identified intangible assets
|
19,280
|
|
|
|
Goodwill
|
15,451
|
|
|
|
Total
|
$
|
35,000
|
|
|
|
Shares Available
for Grant
|
|
|
Shares available as of December 31, 2011
|
2,812,876
|
|
|
Increase in shares approved for issuance
|
6,500,000
|
|
|
Stock options granted (1)
|
(7,592,911
|
)
|
|
Stock options forfeited (2)
|
1,201,539
|
|
|
Stock options expired under former plans
|
(101,562
|
)
|
|
Nonvested equity stock and stock units granted (3)
|
(760,130
|
)
|
|
Nonvested equity stock and stock units forfeited (3)
|
157,973
|
|
|
Total available for grant as of September 30, 2012
|
2,217,785
|
|
|
(1)
|
Amount includes
2,840,986
shares that were granted from the stock option exchange program (discussed below).
|
|
(2)
|
Amount excludes
6,449,255
shares that were surrendered from the stock option exchange program (discussed below) as the shares are no longer available for grant.
|
|
(3)
|
For purposes of determining the number of shares available for grant under the 2006 Plan against the maximum number of shares authorized, each restricted stock granted reduces the number of shares available for grant by
1.5
shares and each restricted stock forfeited increases shares available for grant by
1.5
shares.
|
|
|
Options Outstanding
|
|
|
|
|
|||||||
|
|
Number of
Shares
|
|
Weighted
Average
Exercise Price
Per Share
|
|
Weighted
Average
Remaining
Contractual
Term (years)
|
|
Aggregate
Intrinsic
Value
|
|||||
|
|
(Dollars in thousands, except per share amounts)
|
|||||||||||
|
Outstanding as of December 31, 2011
|
14,587,596
|
|
|
$
|
19.73
|
|
|
|
|
|
|
|
|
Options granted
|
7,592,911
|
|
|
5.83
|
|
|
|
|
|
|
||
|
Options exercised
|
(221,934
|
)
|
|
4.44
|
|
|
|
|
|
|
||
|
Options forfeited
|
(1,201,539
|
)
|
|
11.74
|
|
|
|
|
|
|
||
|
Options surrendered in stock option exchange program
|
(6,449,255
|
)
|
|
21.11
|
|
|
|
|
|
|
||
|
Outstanding as of September 30, 2012
|
14,307,779
|
|
|
12.64
|
|
|
6.22
|
|
$
|
1,506
|
|
|
|
Vested or expected to vest at September 30, 2012
|
12,492,826
|
|
|
13.48
|
|
|
5.84
|
|
1,173
|
|
||
|
Options exercisable at September 30, 2012
|
6,386,017
|
|
|
19.29
|
|
|
3.66
|
|
—
|
|
||
|
|
Stock Option Plans
|
||||||||||||||
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
September 30,
|
|
September 30,
|
||||||||||||
|
|
2012
|
|
2011
|
|
2012
|
|
2011
|
||||||||
|
Stock Option Plans
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Expected stock price volatility
|
65
|
%
|
|
75
|
%
|
|
60-68%
|
|
|
50-75%
|
|
||||
|
Risk free interest rate
|
0.6
|
%
|
|
2.3
|
%
|
|
0.6-0.9%
|
|
|
2.3-2.8%
|
|
||||
|
Expected term (in years)
|
5.5
|
|
|
6.1
|
|
|
5.5-5.7
|
|
|
6.0-6.1
|
|
||||
|
Weighted-average fair value of stock options granted to employees
|
$
|
3.06
|
|
|
$
|
9.48
|
|
|
$
|
3.61
|
|
|
$
|
10.43
|
|
|
|
Employee Stock Purchase Plan
|
|||||||
|
|
|
Nine Months Ended
|
||||||
|
|
|
September 30,
|
||||||
|
|
|
2012
|
|
2011
|
||||
|
Employee Stock Purchase Plan
|
|
|
|
|
|
|
||
|
Expected stock price volatility
|
|
63
|
%
|
|
56
|
%
|
||
|
Risk free interest rate
|
|
0.2
|
%
|
|
0.1
|
%
|
||
|
Expected term (in years)
|
|
0.5
|
|
|
0.5
|
|
||
|
Weighted-average fair value of purchase rights granted under the purchase plan
|
|
$
|
1.61
|
|
|
$
|
5.96
|
|
|
Nonvested Equity Stock and Stock Units
|
|
Shares
|
|
Weighted-
Average
Grant-Date
Fair Value
|
|||
|
Nonvested at December 31, 2011
|
|
763,510
|
|
|
$
|
18.02
|
|
|
Granted
|
|
506,753
|
|
|
6.95
|
|
|
|
Vested
|
|
(312,099
|
)
|
|
18.31
|
|
|
|
Forfeited
|
|
(105,315
|
)
|
|
13.52
|
|
|
|
Nonvested at September 30, 2012
|
|
852,849
|
|
|
11.88
|
|
|
|
|
|
As of September 30, 2012
|
|||||||||||||||||
|
(Dollars in thousands)
|
|
Fair Value
|
|
Amortized
Cost
|
|
Gross
Unrealized
Gains
|
|
Gross
Unrealized
Losses
|
|
Weighted
Rate of
Return
|
|||||||||
|
Money market funds
|
|
$
|
118,508
|
|
|
$
|
118,508
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
0.01
|
%
|
|
Corporate notes, bonds and commercial paper
|
|
56,886
|
|
|
56,906
|
|
|
—
|
|
|
(20
|
)
|
|
0.21
|
%
|
||||
|
Total cash equivalents and marketable securities
|
|
175,394
|
|
|
175,414
|
|
|
—
|
|
|
(20
|
)
|
|
|
|
||||
|
Cash
|
|
31,692
|
|
|
31,692
|
|
|
—
|
|
|
—
|
|
|
|
|
||||
|
Total cash, cash equivalents and marketable securities
|
|
$
|
207,086
|
|
|
$
|
207,106
|
|
|
$
|
—
|
|
|
$
|
(20
|
)
|
|
|
|
|
|
|
As of December 31, 2011
|
|||||||||||||||||
|
(Dollars in thousands)
|
|
Fair Value
|
|
Amortized
Cost
|
|
Gross
Unrealized
Gains
|
|
Gross
Unrealized
Losses
|
|
Weighted
Rate of
Return
|
|||||||||
|
Money market funds
|
|
$
|
127,559
|
|
|
$
|
127,559
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
0.01
|
%
|
|
Corporate notes, bonds and commercial paper
|
|
137,108
|
|
|
137,208
|
|
|
—
|
|
|
(100
|
)
|
|
0.29
|
%
|
||||
|
Total cash equivalents and marketable securities
|
|
264,667
|
|
|
264,767
|
|
|
—
|
|
|
(100
|
)
|
|
|
|
||||
|
Cash
|
|
24,789
|
|
|
24,789
|
|
|
—
|
|
|
—
|
|
|
|
|
||||
|
Total cash, cash equivalents and marketable securities
|
|
$
|
289,456
|
|
|
$
|
289,556
|
|
|
$
|
—
|
|
|
$
|
(100
|
)
|
|
|
|
|
|
September 30,
2012 |
|
December 31,
2011 |
||||
|
|
(Dollars in thousands)
|
||||||
|
Cash equivalents
|
$
|
120,514
|
|
|
$
|
137,455
|
|
|
Short term marketable securities
|
54,880
|
|
|
127,212
|
|
||
|
Total cash equivalents and marketable securities
|
175,394
|
|
|
264,667
|
|
||
|
Cash
|
31,692
|
|
|
24,789
|
|
||
|
Total cash, cash equivalents and marketable securities
|
$
|
207,086
|
|
|
$
|
289,456
|
|
|
|
Fair Value
|
|
Gross Unrealized Loss
|
||||||||||||
|
|
September 30,
2012 |
|
December 31,
2011 |
|
September 30,
2012 |
|
December 31,
2011 |
||||||||
|
|
(In thousands)
|
||||||||||||||
|
Less than one year
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Corporate notes, bonds and commercial paper
|
$
|
46,384
|
|
|
$
|
137,107
|
|
|
$
|
(20
|
)
|
|
$
|
(100
|
)
|
|
|
Total
|
|
Remainder
of 2012
|
|
2013
|
|
2014
|
|
2015
|
|
2016
|
|
Thereafter
|
||||||||||||||
|
Contractual obligations (1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Imputed financing obligation (2)
|
$
|
56,181
|
|
|
$
|
1,682
|
|
|
$
|
6,825
|
|
|
$
|
6,994
|
|
|
$
|
7,165
|
|
|
$
|
7,345
|
|
|
$
|
26,170
|
|
|
Leases and other contractual obligations (3)
|
12,561
|
|
|
5,132
|
|
|
1,818
|
|
|
1,660
|
|
|
1,544
|
|
|
1,049
|
|
|
1,358
|
|
|||||||
|
Software licenses (4)
|
2,545
|
|
|
2,106
|
|
|
359
|
|
|
80
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||
|
Acquisition retention bonuses (5)
|
40,723
|
|
|
2,770
|
|
|
18,207
|
|
|
18,206
|
|
|
1,540
|
|
|
—
|
|
|
—
|
|
|||||||
|
Convertible notes
|
172,500
|
|
|
—
|
|
|
—
|
|
|
172,500
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||
|
Interest payments related to convertible notes
|
17,250
|
|
|
4,313
|
|
|
8,625
|
|
|
4,312
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||
|
Total
|
$
|
301,760
|
|
|
$
|
16,003
|
|
|
$
|
35,834
|
|
|
$
|
203,752
|
|
|
$
|
10,249
|
|
|
$
|
8,394
|
|
|
$
|
27,528
|
|
|
(1)
|
The above table does not reflect possible payments in connection with uncertain tax benefits of approximately
$17.2 million
including
$8.0 million
recorded as a reduction of long-term deferred tax assets and
$9.2 million
in long-term income taxes payable as of
September 30, 2012
. As noted below in Note 9, “Income Taxes,” although it is possible that some of the unrecognized tax benefits could be settled within the next 12 months, the Company cannot reasonably estimate the outcome at this time.
|
|
(2)
|
With respect to the imputed financing obligation, the main components of the difference between the amount reflected in the contractual obligations table and the amount reflected on the Condensed Consolidated Balance Sheets are the interest on the imputed financing obligation and the estimated common area expenses over the future periods. Additionally, the amount includes the amended Ohio lease and the amended Sunnyvale lease.
|
|
(3)
|
Leases and other contractual obligations include the Company's current commitment to purchase intellectual property from Elpida Memory, Inc.
|
|
(4)
|
The Company has commitments with various software vendors for non-cancellable license agreements generally having terms longer than
one
year. The above table summarizes those contractual obligations as of
September 30, 2012
which are also presented on the Company’s Condensed Consolidated Balance Sheet under current and other long-term liabilities.
|
|
(5)
|
In connection with recent acquisitions, the Company is obligated to pay retention bonuses to certain employees and contractors, subject to certain eligibility and acceleration provisions including the condition of employment. The remaining
$33.3 million
of Cryptography Research, Inc. ("CRI") retention bonuses payable on June 3, 2013 and 2014 will be paid in cash or stock at the Company’s election. The portion to be paid in 2012 in the table above includes payments to be made to employees who were affected by the restructuring during the third quarter of 2012. See Note 16, "Restructuring Charges" for further details.
|
|
|
Three Months Ended September 30,
|
||||||||||||||
|
|
2012
|
|
2011
|
||||||||||||
|
|
(In thousands, except per share amounts)
|
||||||||||||||
|
|
CRCS*
|
|
Other CS**
|
|
CRCS*
|
|
Other CS**
|
||||||||
|
Basic net income (loss) per share:
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Numerator:
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Allocation of undistributed earnings
|
$
|
—
|
|
|
$
|
(58,098
|
)
|
|
$
|
11
|
|
|
$
|
467
|
|
|
Denominator:
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Weighted-average common shares outstanding
|
—
|
|
|
110,826
|
|
|
4,788
|
|
|
109,784
|
|
||||
|
Basic net income (loss) per share
|
$
|
—
|
|
|
$
|
(0.52
|
)
|
|
$
|
0.00
|
|
|
$
|
0.00
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Diluted net income (loss) per share:
|
|
|
|
|
|
|
|
||||||||
|
Numerator:
|
|
|
|
|
|
|
|
||||||||
|
Allocation of undistributed earnings for basic computation
|
$
|
—
|
|
|
$
|
(58,098
|
)
|
|
$
|
11
|
|
|
$
|
467
|
|
|
Reallocation of undistributed earnings
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Allocation of undistributed earnings for diluted computation
|
$
|
—
|
|
|
$
|
(58,098
|
)
|
|
$
|
11
|
|
|
$
|
467
|
|
|
Denominator:
|
|
|
|
|
|
|
|
||||||||
|
Number of shares used in basic computation
|
—
|
|
|
110,826
|
|
|
4,788
|
|
|
109,784
|
|
||||
|
Dilutive potential shares from stock options, ESPP, convertible notes, CRI retention bonuses and nonvested equity stock and stock units
|
—
|
|
|
—
|
|
|
—
|
|
|
3,218
|
|
||||
|
Number of shares used in diluted computation
|
—
|
|
|
110,826
|
|
|
4,788
|
|
|
113,002
|
|
||||
|
Diluted net income (loss) per share
|
$
|
—
|
|
|
$
|
(0.52
|
)
|
|
$
|
0.00
|
|
|
$
|
0.00
|
|
|
|
Nine Months Ended September 30,
|
||||||||||||||
|
|
2012
|
|
2011
|
||||||||||||
|
|
(In thousands, except per share amounts)
|
||||||||||||||
|
|
CRCS*
|
|
Other CS**
|
|
CRCS*
|
|
Other CS**
|
||||||||
|
Basic and diluted net loss per share:
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Numerator:
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Allocation of undistributed earnings
|
$
|
—
|
|
|
$
|
(118,204
|
)
|
|
$
|
(526
|
)
|
|
$
|
(13,811
|
)
|
|
Denominator:
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Weighted-average common shares outstanding
|
—
|
|
|
110,580
|
|
|
4,788
|
|
|
105,963
|
|
||||
|
Basic and diluted net loss per share
|
$
|
—
|
|
|
$
|
(1.07
|
)
|
|
$
|
(0.11
|
)
|
|
$
|
(0.13
|
)
|
|
|
For the Three Months Ended September 30, 2012
|
|
For the Nine Months Ended September 30, 2012
|
||||||||||||||||||||
|
|
SBG
|
|
All Other
|
|
Total
|
|
SBG
|
|
All Other
|
|
Total
|
||||||||||||
|
|
(In thousands)
|
|
(In thousands)
|
||||||||||||||||||||
|
Revenues
|
$
|
54,043
|
|
|
$
|
3,487
|
|
|
$
|
57,530
|
|
|
$
|
163,269
|
|
|
$
|
13,339
|
|
|
$
|
176,608
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Segment direct operating income (loss)
|
$
|
44,180
|
|
|
$
|
(5,071
|
)
|
|
$
|
39,109
|
|
|
$
|
126,848
|
|
|
$
|
(14,087
|
)
|
|
$
|
112,761
|
|
|
Reconciling items
|
|
|
|
|
|
|
(86,209
|
)
|
|
|
|
|
|
|
|
(199,168
|
)
|
||||||
|
Total operating loss
|
|
|
|
|
|
|
$
|
(47,100
|
)
|
|
|
|
|
|
|
|
$
|
(86,407
|
)
|
||||
|
Interest and other expense, net
|
|
|
|
|
|
|
(7,133
|
)
|
|
|
|
|
|
|
|
(20,245
|
)
|
||||||
|
Loss before income taxes
|
|
|
|
|
|
|
$
|
(54,233
|
)
|
|
|
|
|
|
|
|
$
|
(106,652
|
)
|
||||
|
|
For the Three Months Ended September 30, 2011
|
|
For the Nine Months Ended September 30, 2011
|
||||||||||||||||||||
|
|
SBG
|
|
All Other
|
|
Total
|
|
SBG
|
|
All Other
|
|
Total
|
||||||||||||
|
|
(In thousands)
|
|
(In thousands)
|
||||||||||||||||||||
|
Revenues
|
$
|
84,628
|
|
|
$
|
15,635
|
|
|
$
|
100,263
|
|
|
$
|
212,779
|
|
|
$
|
16,225
|
|
|
$
|
229,004
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Gain from settlement
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
6,200
|
|
|
$
|
—
|
|
|
$
|
6,200
|
|
|
Segment direct operating income
|
$
|
74,105
|
|
|
$
|
8,491
|
|
|
$
|
82,596
|
|
|
$
|
185,476
|
|
|
$
|
673
|
|
|
$
|
186,149
|
|
|
Reconciling items
|
|
|
|
|
|
|
(71,860
|
)
|
|
|
|
|
|
|
|
(169,551
|
)
|
||||||
|
Total operating income
|
|
|
|
|
|
|
$
|
10,736
|
|
|
|
|
|
|
|
|
$
|
16,598
|
|
||||
|
Interest and other expense, net
|
|
|
|
|
|
|
(6,178
|
)
|
|
|
|
|
|
|
|
(17,991
|
)
|
||||||
|
Income (loss) before income taxes
|
|
|
|
|
|
|
$
|
4,558
|
|
|
|
|
|
|
|
|
$
|
(1,393
|
)
|
||||
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
|
||||||||
|
|
|
September 30,
|
|
September 30,
|
|
||||||||
|
Customer
|
|
2012
|
|
2011
|
|
2012
|
|
2011
|
|
||||
|
Customer A
|
|
38
|
%
|
|
25
|
%
|
|
38
|
%
|
|
30
|
%
|
|
|
Customer B
|
|
*
|
|
|
25
|
%
|
|
*
|
|
|
11
|
%
|
|
|
Customer C
|
|
*
|
|
|
12
|
%
|
|
*
|
|
|
*
|
|
|
|
Customer D
|
|
*
|
|
|
*
|
|
|
*
|
|
|
11
|
%
|
|
|
Customer E
|
|
*
|
|
|
*
|
|
|
10
|
%
|
|
11
|
%
|
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
|
September 30,
|
|
September 30,
|
||||||||||||
|
(In thousands)
|
|
2012
|
|
2011
|
|
2012
|
|
2011
|
||||||||
|
South Korea
|
|
$
|
21,648
|
|
|
$
|
24,641
|
|
|
$
|
66,363
|
|
|
$
|
68,859
|
|
|
Japan
|
|
17,347
|
|
|
19,899
|
|
|
50,818
|
|
|
76,149
|
|
||||
|
USA
|
|
14,309
|
|
|
42,096
|
|
|
45,778
|
|
|
69,897
|
|
||||
|
Canada
|
|
1,983
|
|
|
12,463
|
|
|
5,835
|
|
|
12,758
|
|
||||
|
Asia-Other
|
|
750
|
|
|
167
|
|
|
4,250
|
|
|
330
|
|
||||
|
Europe
|
|
1,493
|
|
|
997
|
|
|
3,564
|
|
|
1,011
|
|
||||
|
Total
|
|
$
|
57,530
|
|
|
$
|
100,263
|
|
|
$
|
176,608
|
|
|
$
|
229,004
|
|
|
Reportable Segment:
|
|
December 31,
2011 |
|
Additions to Goodwill (1)
|
|
Impairment Charge of Goodwill(2)
|
|
September 30,
2012 |
||||||||
|
|
|
(In thousands)
|
||||||||||||||
|
SBG
|
|
$
|
4,454
|
|
|
$
|
15,451
|
|
|
$
|
—
|
|
|
$
|
19,905
|
|
|
All Other
|
|
110,694
|
|
|
8,070
|
|
|
(13,700
|
)
|
|
105,064
|
|
||||
|
Total
|
|
$
|
115,148
|
|
|
$
|
23,521
|
|
|
$
|
(13,700
|
)
|
|
$
|
124,969
|
|
|
(1)
|
The additions to goodwill resulted from two business combinations in the first quarter of 2012. See Note 4, “Acquisitions” for further details.
|
|
(2)
|
The Company recorded a non-cash goodwill impairment charge of
$13.7 million
related to the LDT reporting unit as discussed above.
|
|
|
|
|
As of September 30, 2012
|
||||||||||
|
|
Useful Life
|
|
Gross Carrying
Amount
|
|
Accumulated
Amortization
|
|
Net Carrying
Amount
|
||||||
|
|
|
|
(In thousands)
|
||||||||||
|
Existing technology(1)
|
3 to 10 years
|
|
$
|
181,431
|
|
|
$
|
(40,766
|
)
|
|
$
|
140,665
|
|
|
Customer contracts and contractual relationships
|
1 to 10 years
|
|
32,650
|
|
|
(13,074
|
)
|
|
19,576
|
|
|||
|
Non-compete agreements
|
3 years
|
|
300
|
|
|
(133
|
)
|
|
167
|
|
|||
|
Intellectual property
|
4 years
|
|
10,384
|
|
|
(10,384
|
)
|
|
—
|
|
|||
|
Total intangible assets
|
|
|
$
|
224,765
|
|
|
$
|
(64,357
|
)
|
|
$
|
160,408
|
|
|
|
|
|
As of December 31, 2011
|
||||||||||
|
|
Useful Life
|
|
Gross Carrying
Amount
|
|
Accumulated
Amortization
|
|
Net Carrying
Amount
|
||||||
|
|
|
|
(In thousands)
|
||||||||||
|
Existing technology
|
3 to 10 years
|
|
$
|
187,993
|
|
|
$
|
(32,682
|
)
|
|
$
|
155,311
|
|
|
Customer contracts and contractual relationships
|
1 to 10 years
|
|
33,550
|
|
|
(7,148
|
)
|
|
26,402
|
|
|||
|
Non-compete agreements
|
3 years
|
|
400
|
|
|
(158
|
)
|
|
242
|
|
|||
|
Intellectual property
|
4 years
|
|
10,384
|
|
|
(10,384
|
)
|
|
—
|
|
|||
|
Total intangible assets
|
|
|
$
|
232,327
|
|
|
$
|
(50,372
|
)
|
|
$
|
181,955
|
|
|
(1)
|
The Company recorded a non-cash intangible impairment charge of
$15.4 million
related to the LDT group as discussed above which has been netted from the gross carrying amount and accumulated amortization for existing technology.
|
|
Years Ending December 31:
|
Amount
|
||
|
2012 (remaining 3 months)
|
$
|
8,202
|
|
|
2013
|
31,451
|
|
|
|
2014
|
27,310
|
|
|
|
2015
|
26,660
|
|
|
|
2016
|
25,766
|
|
|
|
Thereafter
|
41,019
|
|
|
|
|
$
|
160,408
|
|
|
|
As of September 30, 2012
|
||||||||||||||
|
|
Total
|
|
Quoted
Market
Prices in
Active
Markets
(Level 1)
|
|
Significant
Other
Observable
Inputs
(Level 2)
|
|
Significant
Unobservable
Inputs
(Level 3)
|
||||||||
|
|
(In thousands)
|
||||||||||||||
|
Money market funds
|
$
|
118,508
|
|
|
$
|
118,508
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Corporate notes, bonds and commercial paper
|
56,886
|
|
|
—
|
|
|
56,886
|
|
|
—
|
|
||||
|
Total available-for-sale securities
|
$
|
175,394
|
|
|
$
|
118,508
|
|
|
$
|
56,886
|
|
|
$
|
—
|
|
|
|
As of December 31, 2011
|
||||||||||||||
|
|
Total
|
|
Quoted
Market
Prices in
Active
Markets
(Level 1)
|
|
Significant
Other
Observable
Inputs
(Level 2)
|
|
Significant
Unobservable
Inputs
(Level 3)
|
||||||||
|
|
(In thousands)
|
||||||||||||||
|
Money market funds
|
$
|
127,559
|
|
|
$
|
127,559
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Corporate notes, bonds and commercial paper
|
137,108
|
|
|
—
|
|
|
137,108
|
|
|
—
|
|
||||
|
Total available-for-sale securities
|
$
|
264,667
|
|
|
$
|
127,559
|
|
|
$
|
137,108
|
|
|
$
|
—
|
|
|
|
|
As of September 30, 2012
|
||||||||||||||||||
|
(in thousands)
|
|
Carrying
Value
|
|
Quoted
market
prices in
active
markets
(Level 1)
|
|
Significant
other
observable
inputs
(Level 2)
|
|
Significant
unobservable
inputs
(Level 3)
|
|
Impairment
charges for the
nine months
ended
September 30,
2012
|
||||||||||
|
Investment in non-marketable securities
|
|
$
|
2,000
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
2,000
|
|
|
$
|
—
|
|
|
|
|
As of December 31, 2011
|
||||||||||||||||||
|
(in thousands)
|
|
Carrying
Value
|
|
Quoted
market
prices in
active
markets
(Level 1)
|
|
Significant
other
observable
inputs
(Level 2)
|
|
Significant
unobservable
inputs
(Level 3)
|
|
Impairment
charges for the
year
ended
December 31,
2011
|
||||||||||
|
Investment in non-marketable securities
|
|
$
|
2,000
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
2,000
|
|
|
$
|
—
|
|
|
|
|
As of September 30, 2012
|
|
As of December 31, 2011
|
||||||||||||||||||||
|
(in thousands)
|
|
Face
Value
|
|
Carrying
Value
|
|
Fair Value
|
|
Face
Value
|
|
Carrying
Value
|
|
Fair Value
|
||||||||||||
|
5% Convertible Senior Notes due 2014
|
|
$
|
172,500
|
|
|
$
|
143,875
|
|
|
$
|
172,500
|
|
|
$
|
172,500
|
|
|
$
|
133,493
|
|
|
$
|
170,289
|
|
|
(Dollars in thousands)
|
|
As of September 30, 2012
|
|
As of December 31, 2011
|
||||
|
5% Convertible Senior Notes due 2014 (the “2014 Notes”)
|
|
$
|
172,500
|
|
|
$
|
172,500
|
|
|
Unamortized discount
|
|
(28,625
|
)
|
|
(39,007
|
)
|
||
|
Total convertible notes
|
|
$
|
143,875
|
|
|
$
|
133,493
|
|
|
Less current portion
|
|
—
|
|
|
—
|
|
||
|
Total long-term convertible notes
|
|
$
|
143,875
|
|
|
$
|
133,493
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
September 30,
|
|
September 30,
|
||||||||||||
|
|
2012
|
|
2011
|
|
2012
|
|
2011
|
||||||||
|
|
(In thousands)
|
||||||||||||||
|
2014 Notes coupon interest at a rate of 5%
|
$
|
2,156
|
|
|
$
|
2,156
|
|
|
$
|
6,469
|
|
|
$
|
6,468
|
|
|
2014 Notes amortization of discount and debt issuance costs at an additional effective interest rate of 11.7%
|
3,789
|
|
|
3,254
|
|
|
10,856
|
|
|
9,326
|
|
||||
|
Total interest expense on convertible notes
|
$
|
5,945
|
|
|
$
|
5,410
|
|
|
$
|
17,325
|
|
|
$
|
15,794
|
|
|
|
|
Employee
Severance
and Related Benefits
|
|
Other Expenses
|
|
Total
|
|||||
|
|
|
(in thousands)
|
|||||||||
|
Balance at December 31, 2011
|
|
—
|
|
|
—
|
|
|
—
|
|
||
|
Charges
|
|
6,622
|
|
|
—
|
|
|
6,622
|
|
||
|
Payments
|
|
(1,788
|
)
|
|
—
|
|
|
(1,788
|
)
|
||
|
Balance at September 30, 2012
|
|
$
|
4,834
|
|
|
—
|
|
|
$
|
4,834
|
|
|
Double Data Rate
|
DDR
|
|
Dynamic Random Access Memory
|
DRAM
|
|
Gigabits per second
|
Gb/s
|
|
Graphics Double Data Rate
|
GDDR
|
|
Input/Output
|
I/O
|
|
Light Emitting Diodes
|
LED
|
|
Liquid Crystal Display
|
LCD
|
|
Peripheral Component Interconnect
|
PCI
|
|
Rambus Dynamic Random Access Memory
|
RDRAM
™
|
|
Single Data Rate
|
SDR
|
|
Synchronous Dynamic Random Access Memory
|
SDRAM
|
|
eXtreme Data Rate
|
XDR
™
|
|
Advanced Micro Devices Inc.
|
AMD
|
|
Broadcom Corporation
|
Broadcom
|
|
Cooper Lighting, LLC
|
Cooper Lighting
|
|
Cryptography Research, Inc.
|
CRI
|
|
Elpida Memory, Inc.
|
Elpida
|
|
Freescale Semiconductor Inc.
|
Freescale
|
|
Fujitsu Limited
|
Fujitsu
|
|
General Electric Company
|
GE
|
|
Global Lighting Technologies, Inc.
|
GLT
|
|
Hewlett-Packard Company
|
Hewlett-Packard
|
|
Hynix Semiconductor, Inc.
|
Hynix
|
|
Infineon Technologies AG
|
Infineon
|
|
Inotera Memories, Inc.
|
Inotera
|
|
Intel Corporation
|
Intel
|
|
International Business Machines Corporation
|
IBM
|
|
Joint Electronic Device Engineering Councils
|
JEDEC
|
|
Lighting and Display Technology
|
LDT
|
|
LSI Corporation
|
LSI
|
|
MediaTek Inc.
|
MediaTek
|
|
Memory and Interfaces Division
|
MID
|
|
Micron Technologies, Inc.
|
Micron
|
|
Mobile Technology Division
|
MTD
|
|
Nanya Technology Corporation
|
Nanya
|
|
New Business Group
|
NBG
|
|
NEC Electronics Corporation
|
NEC
|
|
NVIDIA Corporation
|
NVIDIA
|
|
Qimonda AG (formerly Infineon’s DRAM operations)
|
Qimonda
|
|
Panasonic Corporation
|
Panasonic
|
|
Renesas Electronics
|
Renesas
|
|
Samsung Electronics Co., Ltd.
|
Samsung
|
|
Semiconductor Business Group
|
SBG
|
|
Sony Computer Electronics
|
Sony
|
|
Spansion, Inc.
|
Spansion
|
|
ST Microelectronics N.V.
|
ST Microelectronics
|
|
Texas Instruments Inc.
|
Texas Instruments
|
|
Toshiba Corporation
|
Toshiba
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||
|
|
September 30,
|
|
September 30,
|
||||||||
|
|
2012
|
|
2011
|
|
2012
|
|
2011
|
||||
|
Revenue:
|
|
|
|
|
|
|
|
|
|
|
|
|
Royalties
|
99.7
|
%
|
|
96.0
|
%
|
|
99.2
|
%
|
|
94.5
|
%
|
|
Contract revenue
|
0.3
|
%
|
|
4.0
|
%
|
|
0.8
|
%
|
|
5.5
|
%
|
|
Total revenue
|
100.0
|
%
|
|
100.0
|
%
|
|
100.0
|
%
|
|
100.0
|
%
|
|
Operating costs and expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of revenue*
|
13.1
|
%
|
|
7.4
|
%
|
|
12.5
|
%
|
|
7.3
|
%
|
|
Research and development*
|
53.3
|
%
|
|
32.3
|
%
|
|
60.8
|
%
|
|
34.9
|
%
|
|
Marketing, general and administrative*
|
42.2
|
%
|
|
48.8
|
%
|
|
51.7
|
%
|
|
52.1
|
%
|
|
Restructuring charges
|
11.5
|
%
|
|
—
|
%
|
|
3.7
|
%
|
|
—
|
%
|
|
Impairment of goodwill and long-lived assets
|
61.7
|
%
|
|
—
|
%
|
|
20.1
|
%
|
|
—
|
%
|
|
Costs of restatement and related legal activities
|
0.1
|
%
|
|
0.8
|
%
|
|
0.1
|
%
|
|
1.2
|
%
|
|
Gain from settlement
|
—
|
%
|
|
—
|
%
|
|
—
|
%
|
|
(2.7
|
)%
|
|
Total operating costs and expenses
|
181.9
|
%
|
|
89.3
|
%
|
|
148.9
|
%
|
|
92.8
|
%
|
|
Operating income (loss)
|
(81.9
|
)%
|
|
10.7
|
%
|
|
(48.9
|
)%
|
|
7.2
|
%
|
|
Interest income and other income (expense), net
|
0.0
|
%
|
|
0.2
|
%
|
|
0.1
|
%
|
|
0.2
|
%
|
|
Interest expense
|
(12.4
|
)%
|
|
(6.4
|
)%
|
|
(11.6
|
)%
|
|
(8.0
|
)%
|
|
Interest and other income (expense), net
|
(12.4
|
)%
|
|
(6.2
|
)%
|
|
(11.5
|
)%
|
|
(7.8
|
)%
|
|
Income (loss) before income taxes
|
(94.3
|
)%
|
|
4.5
|
%
|
|
(60.4
|
)%
|
|
(0.6
|
)%
|
|
Provision for income taxes
|
6.7
|
%
|
|
4.0
|
%
|
|
6.5
|
%
|
|
5.7
|
%
|
|
Net income (loss)
|
(101.0
|
)%
|
|
0.5
|
%
|
|
(66.9
|
)%
|
|
(6.3
|
)%
|
|
Cost of revenue
|
0.0
|
%
|
|
0.1
|
%
|
|
0.0
|
%
|
|
0.2
|
%
|
|
Research and development
|
3.9
|
%
|
|
2.8
|
%
|
|
4.3
|
%
|
|
3.4
|
%
|
|
Marketing, general and administrative
|
5.0
|
%
|
|
4.3
|
%
|
|
5.9
|
%
|
|
5.8
|
%
|
|
|
|
Three Months
|
|
|
|
Nine Months
|
|
|
||||||||||||||
|
|
|
Ended September 30,
|
|
Change in
|
|
Ended September 30,
|
|
Change in
|
||||||||||||||
|
(Dollars in millions)
|
|
2012
|
|
2011
|
|
Percentage
|
|
2012
|
|
2011
|
|
Percentage
|
||||||||||
|
Total Revenue
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Royalties
|
|
$
|
57.3
|
|
|
$
|
96.2
|
|
|
(40.4
|
)%
|
|
$
|
175.1
|
|
|
$
|
216.4
|
|
|
(19.1
|
)%
|
|
Contract revenue
|
|
0.2
|
|
|
4.1
|
|
|
(95.8
|
)%
|
|
1.5
|
|
|
12.6
|
|
|
(88.2
|
)%
|
||||
|
Total revenue
|
|
$
|
57.5
|
|
|
$
|
100.3
|
|
|
(42.6
|
)%
|
|
$
|
176.6
|
|
|
$
|
229.0
|
|
|
(22.9
|
)%
|
|
|
|
Three Months Ended
|
|
|
|
Nine Months Ended
|
|
|
||||||||||||||
|
|
|
September 30,
|
|
Change in
|
|
September 30,
|
|
Change in
|
||||||||||||||
|
(Dollars in millions)
|
|
2012
|
|
2011
|
|
Percentage
|
|
2012
|
|
2011
|
|
Percentage
|
||||||||||
|
Engineering costs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Cost of revenue
|
|
$
|
0.2
|
|
|
$
|
0.8
|
|
|
(73.4
|
)%
|
|
$
|
0.5
|
|
|
$
|
4.1
|
|
|
(88.7
|
)%
|
|
Amortization of intangible assets
|
|
7.3
|
|
|
6.5
|
|
|
11.9
|
%
|
|
21.5
|
|
|
12.0
|
|
|
79.7
|
%
|
||||
|
Stock-based compensation
|
|
0.0
|
|
|
0.1
|
|
|
(94.4
|
)%
|
|
0.0
|
|
|
0.5
|
|
|
(96.0
|
)%
|
||||
|
Total cost of revenue
|
|
7.5
|
|
|
7.4
|
|
|
1.4
|
%
|
|
22.0
|
|
|
16.6
|
|
|
32.5
|
%
|
||||
|
Research and development
|
|
28.5
|
|
|
29.5
|
|
|
(3.7
|
)%
|
|
99.9
|
|
|
72.1
|
|
|
38.5
|
%
|
||||
|
Stock-based compensation
|
|
2.2
|
|
|
2.8
|
|
|
(20.0
|
)%
|
|
7.5
|
|
|
7.8
|
|
|
(2.6
|
)%
|
||||
|
Total research and development
|
|
30.7
|
|
|
32.3
|
|
|
(5.1
|
)%
|
|
107.4
|
|
|
79.9
|
|
|
34.5
|
%
|
||||
|
Total engineering costs
|
|
$
|
38.2
|
|
|
$
|
39.7
|
|
|
(3.9
|
)%
|
|
$
|
129.4
|
|
|
$
|
96.5
|
|
|
34.2
|
%
|
|
|
|
Three Months Ended
|
|
|
|
Nine Months Ended
|
|
|
||||||||||||||
|
|
|
September 30,
|
|
Change in
|
|
September 30,
|
|
Change in
|
||||||||||||||
|
(Dollars in millions)
|
|
2012
|
|
2011
|
|
Percentage
|
|
2012
|
|
2011
|
|
Percentage
|
||||||||||
|
Marketing, general and administrative costs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Marketing, general and administrative costs
|
|
$
|
18.8
|
|
|
$
|
21.1
|
|
|
(10.6
|
)%
|
|
$
|
69.7
|
|
|
$
|
61.9
|
|
|
12.5
|
%
|
|
Litigation expense
|
|
2.6
|
|
|
23.5
|
|
|
(89.1
|
)%
|
|
11.2
|
|
|
44.2
|
|
|
(74.8
|
)%
|
||||
|
Stock-based compensation
|
|
2.9
|
|
|
4.4
|
|
|
(34.2
|
)%
|
|
10.4
|
|
|
13.3
|
|
|
(21.3
|
)%
|
||||
|
Total marketing, general and administrative costs
|
|
$
|
24.3
|
|
|
$
|
49.0
|
|
|
(50.5
|
)%
|
|
$
|
91.3
|
|
|
$
|
119.4
|
|
|
(23.6
|
)%
|
|
|
|
Three Months Ended
|
|
|
|
Nine Months Ended
|
|
|
||||||||||||||
|
|
|
September 30,
|
|
Change in
|
|
September 30,
|
|
Change in
|
||||||||||||||
|
(Dollars in millions)
|
|
2012
|
|
2011
|
|
Percentage
|
|
2012
|
|
2011
|
|
Percentage
|
||||||||||
|
Restructuring charges
|
|
$
|
6.6
|
|
|
$
|
—
|
|
|
100.0
|
%
|
|
$
|
6.6
|
|
|
$
|
—
|
|
|
100.0
|
%
|
|
|
|
Three Months Ended
|
|
|
|
Nine Months Ended
|
|
|
||||||||||||||
|
|
|
September 30,
|
|
Change in
|
|
September 30,
|
|
Change in
|
||||||||||||||
|
(Dollars in millions)
|
|
2012
|
|
2011
|
|
Percentage
|
|
2012
|
|
2011
|
|
Percentage
|
||||||||||
|
Impairment of goodwill and long-lived assets
|
|
$
|
35.5
|
|
|
$
|
—
|
|
|
100.0
|
%
|
|
$
|
35.5
|
|
|
$
|
—
|
|
|
100.0
|
%
|
|
|
|
Three Months Ended
|
|
|
|
Nine Months Ended
|
|
|
||||||||||||||
|
|
|
September 30,
|
|
Change in
|
|
September 30,
|
|
Change in
|
||||||||||||||
|
(Dollars in millions)
|
|
2012
|
|
2011
|
|
Percentage
|
|
2012
|
|
2011
|
|
Percentage
|
||||||||||
|
Cost of restatement and related legal activities
|
|
$
|
0.1
|
|
|
$
|
0.8
|
|
|
(90.5
|
)%
|
|
$
|
0.2
|
|
|
$
|
2.7
|
|
|
(92.9
|
)%
|
|
|
|
Three Months Ended
|
|
|
|
Nine Months Ended
|
|
|
||||||||||||||
|
|
|
September 30,
|
|
Change in
|
|
September 30,
|
|
Change in
|
||||||||||||||
|
(Dollars in millions)
|
|
2012
|
|
2011
|
|
Percentage
|
|
2012
|
|
2011
|
|
Percentage
|
||||||||||
|
Gain from settlement
|
|
$
|
—
|
|
|
$
|
—
|
|
|
—
|
%
|
|
$
|
—
|
|
|
$
|
6.2
|
|
|
(100.0
|
)%
|
|
|
|
Three Months
|
|
|
|
Nine Months
|
|
|
||||||||||||||
|
|
|
Ended September 30,
|
|
Change in
|
|
Ended September 30,
|
|
Change in
|
||||||||||||||
|
(Dollars in millions)
|
|
2012
|
|
2011
|
|
Percentage
|
|
2012
|
|
2011
|
|
Percentage
|
||||||||||
|
Interest income and other income (expense), net
|
|
$
|
—
|
|
|
$
|
0.2
|
|
|
(107.0
|
)%
|
|
$
|
0.2
|
|
|
$
|
0.5
|
|
|
(62.8
|
)%
|
|
Interest expense
|
|
(7.1
|
)
|
|
(6.4
|
)
|
|
12.1
|
%
|
|
(20.4
|
)
|
|
(18.5
|
)
|
|
10.6
|
%
|
||||
|
Interest and other income (expense), net
|
|
$
|
(7.1
|
)
|
|
$
|
(6.2
|
)
|
|
15.5
|
%
|
|
$
|
(20.2
|
)
|
|
$
|
(18.0
|
)
|
|
12.5
|
%
|
|
|
|
Three Months Ended
|
|
|
|
Nine Months Ended
|
|
|
||||||||||||||
|
|
|
September 30,
|
|
Change in
|
|
September 30,
|
|
Change in
|
||||||||||||||
|
(Dollars in millions)
|
|
2012
|
|
2011
|
|
Percentage
|
|
2012
|
|
2011
|
|
Percentage
|
||||||||||
|
Provision for income taxes
|
|
$
|
3.9
|
|
|
$
|
4.1
|
|
|
(5.3
|
)%
|
|
$
|
11.6
|
|
|
$
|
12.9
|
|
|
(10.8
|
)%
|
|
Effective tax rate
|
|
(7.1
|
)%
|
|
89.5
|
%
|
|
|
|
|
(10.8
|
)%
|
|
(929.2
|
)%
|
|
|
|
||||
|
|
As of
|
||||||
|
|
September 30,
2012 |
|
December 31,
2011 |
||||
|
|
(In millions)
|
||||||
|
Cash and cash equivalents
|
$
|
152.2
|
|
|
$
|
162.2
|
|
|
Marketable securities
|
54.9
|
|
|
127.2
|
|
||
|
Total cash, cash equivalents, and marketable securities
|
$
|
207.1
|
|
|
$
|
289.4
|
|
|
|
Nine Months Ended
|
||||||
|
|
September 30,
|
||||||
|
|
2012
|
|
2011
|
||||
|
|
(In millions)
|
||||||
|
Net cash provided by (used in) operating activities
|
$
|
(19.7
|
)
|
|
$
|
51.0
|
|
|
Net cash provided by (used in) investing activities
|
$
|
8.1
|
|
|
$
|
(22.4
|
)
|
|
Net cash provided by (used in) financing activities
|
$
|
1.6
|
|
|
$
|
(83.0
|
)
|
|
|
Total
|
|
Remainder
of 2012
|
|
2013
|
|
2014
|
|
2015
|
|
2016
|
|
Thereafter
|
||||||||||||||
|
Contractual obligations (1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
|
Imputed financing obligation (2)
|
$
|
56,181
|
|
|
$
|
1,682
|
|
|
$
|
6,825
|
|
|
$
|
6,994
|
|
|
$
|
7,165
|
|
|
$
|
7,345
|
|
|
$
|
26,170
|
|
|
Leases and other contractual obligations (3)
|
12,561
|
|
|
5,132
|
|
|
1,818
|
|
|
1,660
|
|
|
1,544
|
|
|
1,049
|
|
|
1,358
|
|
|||||||
|
Software licenses (4)
|
2,545
|
|
|
2,106
|
|
|
359
|
|
|
80
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||
|
Acquisition retention bonuses (5)
|
40,723
|
|
|
2,770
|
|
|
18,207
|
|
|
18,206
|
|
|
1,540
|
|
|
—
|
|
|
—
|
|
|||||||
|
Convertible notes
|
172,500
|
|
|
—
|
|
|
—
|
|
|
172,500
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||
|
Interest payments related to convertible notes
|
17,250
|
|
|
4,313
|
|
|
8,625
|
|
|
4,312
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||
|
Total
|
$
|
301,760
|
|
|
$
|
16,003
|
|
|
$
|
35,834
|
|
|
$
|
203,752
|
|
|
$
|
10,249
|
|
|
$
|
8,394
|
|
|
$
|
27,528
|
|
|
(1)
|
The above table does not reflect possible payments in connection with uncertain tax benefits of approximately
$17.2 million
including
$8.0 million
recorded as a reduction of long-term deferred tax assets and
$9.2 million
in long-term income taxes payable, as of
September 30, 2012
. As noted in Note 9, “Income Taxes,” of Notes to Unaudited Condensed Consolidated Financial Statements of this Form 10-Q although it is possible that some of the unrecognized tax benefits could be settled within the next 12 months, we cannot reasonably estimate the outcome at this time.
|
|
(2)
|
With respect to the imputed financing obligation, the main components of the difference between the amount reflected in the contractual obligations table and the amount reflected on the Condensed Consolidated Balance Sheets are the interest on the imputed financing obligation and the estimated common area expenses over the future periods. Additionally, the amount includes the amended Ohio lease and the amended Sunnyvale lease.
|
|
(3)
|
Leases and other contractual obligations include our current commitment to purchase intellectual property from Elpida.
|
|
(4)
|
We have commitments with various software vendors for non-cancellable license agreements generally having terms longer than
one
year. The above table summarizes those contractual obligations as of
September 30, 2012
which are also presented on our Condensed Consolidated Balance Sheet under current and other long-term liabilities.
|
|
(5)
|
In connection with recent acquisitions, we are obligated to pay retention bonuses to certain employees and contractors, subject to certain eligibility and acceleration provisions including the condition of employment. The remaining
$33.3 million
of CRI retention bonuses payable on June 3, 2013 and 2014 will be paid in cash or stock at our election. The portion to be paid in 2012 in the table above includes payments to be made to employees who were affected by the restructuring during the third quarter of 2012. See Note 16, "Restructuring Charges," of Notes to Unaudited Condensed Consolidated Financial Statements of this Form 10-Q for further details.
|
|
|
|
As of September 30, 2012
|
|||||||||||||||||
|
(Dollars in thousands)
|
|
Fair Value
|
|
Amortized
Cost
|
|
Gross
Unrealized
Gains
|
|
Gross
Unrealized
Losses
|
|
Weighted
Rate of
Return
|
|||||||||
|
Money market funds
|
|
$
|
118,508
|
|
|
$
|
118,508
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
0.01
|
%
|
|
Corporate notes, bonds and commercial paper
|
|
56,886
|
|
|
56,906
|
|
|
—
|
|
|
(20
|
)
|
|
0.21
|
%
|
||||
|
Total cash equivalents and marketable securities
|
|
175,394
|
|
|
175,414
|
|
|
—
|
|
|
(20
|
)
|
|
|
|
||||
|
Cash
|
|
31,692
|
|
|
31,692
|
|
|
—
|
|
|
—
|
|
|
|
|
||||
|
Total cash, cash equivalents and marketable securities
|
|
$
|
207,086
|
|
|
$
|
207,106
|
|
|
$
|
—
|
|
|
$
|
(20
|
)
|
|
|
|
|
|
|
As of December 31, 2011
|
|||||||||||||||||
|
(Dollars in thousands)
|
|
Fair Value
|
|
Amortized
Cost
|
|
Gross
Unrealized
Gains
|
|
Gross
Unrealized
Losses
|
|
Weighted
Rate of
Return
|
|||||||||
|
Money market funds
|
|
$
|
127,559
|
|
|
$
|
127,559
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
0.01
|
%
|
|
Corporate notes, bonds and commercial paper
|
|
137,108
|
|
|
137,208
|
|
|
—
|
|
|
(100
|
)
|
|
0.29
|
%
|
||||
|
Total cash equivalents and marketable securities
|
|
264,667
|
|
|
264,767
|
|
|
—
|
|
|
(100
|
)
|
|
|
|
||||
|
Cash
|
|
24,789
|
|
|
24,789
|
|
|
—
|
|
|
—
|
|
|
|
|
||||
|
Total cash, cash equivalents and marketable securities
|
|
$
|
289,456
|
|
|
$
|
289,556
|
|
|
$
|
—
|
|
|
$
|
(100
|
)
|
|
|
|
|
(in thousands)
|
|
Fair Value
|
|
Fair Value Given a
10%
Increase in Market
Prices
|
|
Fair Value Given a
10%
Decrease in Market
Prices
|
||||||
|
5% Convertible Senior Notes due 2014
|
|
$
|
172,500
|
|
|
$
|
189,750
|
|
|
$
|
155,250
|
|
|
•
|
competition faced by a company in its particular industry;
|
|
•
|
the timely introduction and market acceptance of a company’s products;
|
|
•
|
the engineering, sales and marketing and management capabilities of a company;
|
|
•
|
technical challenges unrelated to our innovations faced by a company in developing its products;
|
|
•
|
the financial and other resources of a company; and
|
|
•
|
the degree to which our licensees promote our innovations to their customers.
|
|
•
|
completed before changes in the semiconductor industry render them obsolete;
|
|
•
|
available when system companies require these innovations; and
|
|
•
|
sufficiently compelling to cause semiconductor manufacturers to enter into licensing arrangements with us to implement these new technologies.
|
|
•
|
expenditure of significant financial and research and development resources in efforts to analyze, correct, eliminate or work-around breaches, errors or defects or to address and eliminate vulnerabilities;
|
|
•
|
financial liability to licensees for breach of certain contract provisions;
|
|
•
|
loss of existing or potential licensees;
|
|
•
|
delayed or lost revenue;
|
|
•
|
delay or failure to attain market acceptance;
|
|
•
|
negative publicity, which will harm our reputation; and
|
|
•
|
litigation, regulatory inquiries or investigations that may be costly and harm our reputation.
|
|
•
|
the key personnel of the acquired entity or business may decide not to work for us or may not perform according to our expectations;
|
|
•
|
we may experience additional legal, financial and accounting challenges and complexities in areas such as licensing, tax planning, cash management and financial reporting;
|
|
•
|
we may experience challenges with existing or prospective licensees as a result of potential conflict between pre-existing and historical relationships and any newly acquired engagements and agreements;
|
|
•
|
our ongoing business, including our operations, technology development and deliveries to our customers, may be disrupted, and employee retention and productivity could also suffer;
|
|
•
|
we may not be able to recognize the financial benefits we anticipated and/or we may suffer losses, both with respect to our ongoing business and the acquired entity or business;
|
|
•
|
our increasing international presence resulting from acquisitions may lead to additional risks associated with operating outside the United States, including with respect to legal, employment and other areas of focus, and may increase our exposure to international currency, tax and political risks; and
|
|
•
|
our lack of experience with new products or technologies in new markets may cause us to fail to achieve expected financial and strategic benefits of the acquisition.
|
|
•
|
export controls, tariffs, import and licensing restrictions and other trade barriers;
|
|
•
|
profits, if any, earned abroad being subject to local tax laws and not being repatriated to the United States or, if repatriation is possible, limited in amount;
|
|
•
|
treatment of revenue from international sources and changes to tax codes, including being subject to foreign tax laws and being liable for paying withholding, income or other taxes in foreign jurisdictions, such as withholding taxes in Korea;
|
|
•
|
foreign government laws and regulations and changes in these laws and regulations;
|
|
•
|
lack of protection of our intellectual property and other contract rights by jurisdictions in which we may do business to the same extent as the laws of the United States;
|
|
•
|
hiring, maintaining and managing a workforce remotely and under various legal systems;
|
|
•
|
natural disasters, acts of war, terrorism, widespread illness or securities breaches;
|
|
•
|
social, political and economic instability;
|
|
•
|
geo-political issues; including changes in diplomatic and trade relationships; and
|
|
•
|
cultural differences in the conduct of business both with licensees and in conducting business in our international facilities and international sales offices.
|
|
•
|
new litigation or developments in current litigation, including an unfavorable outcome to us from court proceedings relating to our ongoing litigation and reaction to any settlements that we enter into with former litigants, such as the November 2011 verdict against us in our San Francisco antitrust proceeding, and the unpredictability of litigation results or settlements and the timing and amount of any litigation expenses;
|
|
•
|
any progress, or lack of progress, real or perceived, in the development of products that incorporate our innovations and technology companies’ acceptance of our products, including the results of our efforts to expand into new target markets;
|
|
•
|
our signing or not signing new licensees and the loss of strategic relationships with any licensee;
|
|
•
|
the success of high volume consumer applications;
|
|
•
|
the dependence of our royalties upon fluctuating sales volumes and prices of products that include our technology, including the seasonal shipment patterns of systems incorporating our products and semiconductor or system companies discontinuing major products incorporating our products;
|
|
•
|
announcements of our technological innovations or new products by us, our licensees or our competitors;
|
|
•
|
changes in our customers’ development schedules and levels of expenditure on research and development;
|
|
•
|
our licensees terminating or failing to make payments under their current contracts or seeking to modify such contracts, whether voluntarily or as a result of financial difficulties;
|
|
•
|
changes in our strategies, including changes in our licensing focus and/or acquisitions of companies with business models or target markets different from our own;
|
|
•
|
changes in the economy and credit market and their effects upon demand for our technology and the products of our licensees;
|
|
•
|
positive or negative reports by securities analysts as to our expected financial results and business developments;
|
|
•
|
developments with respect to patents or proprietary rights and other events or factors;
|
|
•
|
trading activity related to our share repurchase plans; and
|
|
•
|
issuance of additional securities by us, including in acquisitions.
|
|
•
|
our ability to obtain additional financing in the future for working capital, capital expenditures, acquisitions, litigation, general corporate or other purposes may be limited;
|
|
•
|
a substantial portion of our cash flows from operations in the future will be dedicated to the payment of the principal of our indebtedness as we are required to pay the principal amount of our 2014 Notes in cash upon conversion if specified conditions are met or when due;
|
|
•
|
if upon any conversion of our 2014 Notes we are required to satisfy our conversion obligation with shares of our common stock or we are required to pay a “make-whole” premium with shares of our common stock, our existing stockholders’ interest in us would be diluted; and
|
|
•
|
we may be more vulnerable to economic downturns, less able to withstand competitive pressures and less flexible in responding to changing business and economic conditions.
|
|
•
|
our board of directors is authorized, without prior stockholder approval, to create and issue preferred stock, commonly referred to as “blank check” preferred stock, with rights senior to those of common stock, which means that a new stockholder rights plan could be implemented by our board to replace our old plan that expired in 2010;
|
|
•
|
our board of directors is staggered into two classes, only one of which is elected at each annual meeting;
|
|
•
|
stockholder action by written consent is prohibited;
|
|
•
|
nominations for election to our board of directors and the submission of matters to be acted upon by stockholders at a meeting are subject to advance notice requirements;
|
|
•
|
certain provisions in our bylaws and certificate of incorporation such as notice to stockholders, the ability to call a stockholder meeting, advance notice requirements and action of stockholders by written consent may only be amended with the approval of stockholders holding 66 2/3% of our outstanding voting stock;
|
|
•
|
our stockholders have no authority to call special meetings of stockholders; and
|
|
•
|
our board of directors is expressly authorized to make, alter or repeal our bylaws.
|
|
•
|
any current or future U.S. or foreign patent applications will be approved and not be challenged by third parties;
|
|
•
|
our issued patents will protect our intellectual property and not be challenged by third parties;
|
|
•
|
the validity of our patents will be upheld;
|
|
•
|
our patents will not be declared unenforceable;
|
|
•
|
the patents of others will not have an adverse effect on our ability to do business;
|
|
•
|
Congress or the U.S. courts or foreign countries will not change the nature or scope of rights afforded patents or patent owners or alter in an adverse way the process for seeking or enforcing patents;
|
|
•
|
changes in law will not be implemented, or changes in interpretation of such laws will occur, that will affect our ability to protect and enforce our patents and other intellectual property, including as a result of the passage of the America Invents Act of 2011 (which codifies several significant changes to the U.S. patent laws and will remain subject to certain rule-making and interpretation, including changing from a “first to invent” to a “first inventor to file” system, limiting where a patentee may file a patent suit, requiring the apportionment of patent damages, replacing interference proceedings with derivation actions, and creating a post-grant opposition process to challenge patents after they have issued);
|
|
•
|
new legal theories and strategies utilized by our competitors will not be successful;
|
|
•
|
others will not independently develop similar or competing chip interfaces or design around any patents that may be issued to us; or
|
|
•
|
factors such as difficulty in obtaining cooperation from inventors, pre-existing challenges or litigation, or license or other contract issues will not present additional challenges in securing protection with respect to patents and other intellectual property that we acquire.
|
|
|
RAMBUS INC.
|
|
|
|
|
|
|
Date: October 29, 2012
|
By:
|
/s/ Satish Rishi
|
|
|
|
Satish Rishi
|
|
|
|
Senior Vice President, Finance and
|
|
|
|
Chief Financial Officer
|
|
Exhibit
Number
|
|
Description of Document
|
|
|
|
|
|
3.1 (1)
|
|
Amended and Restated Certificate of Incorporation of Registrant filed May 29, 1997.
|
|
|
|
|
|
3.2 (2)
|
|
Certificate of Amendment of Amended and Restated Certificate of Incorporation of Registrant filed June 14, 2000.
|
|
|
|
|
|
3.3 (3)
|
|
Amended and Restated Bylaws of Registrant dated February 23, 2012.
|
|
|
|
|
|
10.1*
|
|
Separation Agreement between Sharon Holt and the Registrant, dated as of August 30, 2012.
|
|
|
|
|
|
31.1
|
|
Certification of Principal Executive Officer, pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
31.2
|
|
Certification of Principal Financial Officer, pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
32.1
|
|
Certification of Principal Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
32.2
|
|
Certification of Principal Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
101.INS
|
|
XBRL Instance Document
|
|
|
|
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
(1)
|
Incorporated by reference to the Form 10-K filed on December 15, 1997.
|
|
(2)
|
Incorporated by reference to the Form 10-Q filed on May 4, 2001.
|
|
(3)
|
Incorporated by reference to the Form 8-K filed on February 28, 2012.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|